Related references
Note: Only part of the references are listed.Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells
Jillian Cornish et al.
BONE (2011)
Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis
M. Manfredi et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2011)
Odanacatib in the Treatment of Postmenopausal Women With Low Bone Mineral Density: Three-Year Continued Therapy and Resolution of Effect
John A. Eisman et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
A Single Infusion of Zoledronic Acid Produces Sustained Remissions in Paget Disease: Data to 6.5 Years
Ian R. Reid et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Outcome of treatment and parameters influencing recurrence in patients with bisphosphonate-related osteonecrosis of the jaws
Thomas Muecke et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
David H. Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Risk Factors for Osteonecrosis of the Jaws: a Case-Control Study from the CONDOR Dental PBRN
A. Barasch et al.
JOURNAL OF DENTAL RESEARCH (2011)
Relevance Of a Prolonged Preoperative Antibiotic Regime in the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw
Sebastian Hoefert et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2011)
Osteonecrosis of the Jaw and the Role of Macrophages
Michael Pazianas
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study
Karim Fizazi et al.
LANCET (2011)
Oral biofilm challenge regulates the RANKL-OPG system in periodontal ligament and dental pulp cells
Georgios N. Belibasakis et al.
MICROBIAL PATHOGENESIS (2011)
Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study
Paolo Vescovi et al.
ORAL ONCOLOGY (2011)
Do RANKL inhibitors (denosumab) affect inflammation and immunity?
S. Ferrari-Lacraz et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Nonexposed Variant of Bisphosphonate-associated Osteonecrosis of the Jaw: A Case Series
Stefano Fedele et al.
AMERICAN JOURNAL OF MEDICINE (2010)
Fatigue in bone: A novel phenomenon attributable to bisphosphonate use
Athanassios Kyrgidis et al.
BONE (2010)
Randomized Trial of Intensive Bisphosphonate Treatment Versus Symptomatic Management in Paget's Disease of Bone
Anne L. Langston et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Effects of Denosumab on Bone Histomorphometry: The FREEDOM and STAND Studies
Ian R. Reid et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases
O. Filleul et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
Alison T. Stopeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Occurrence of Bisphosphonate-Related Osteonecrosis of the Jaw After Surgical Tooth Extraction
Giorgia Saia et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2010)
Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure
Joan C. Lo et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2010)
The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid Data from the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly clinical trials program
John T. Grbic et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2010)
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Gareth J. Morgan et al.
LANCET (2010)
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
Peter Gimsing et al.
LANCET ONCOLOGY (2010)
Teriparatide Therapy for Alendronate-Associated Osteonecrosis of the Jaw
Ada Cheung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Increased risk of serious infections in women with osteopenia or osteoporosis treated with denosumab
K. A. Toulis et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Jaw Osteonecrosis in Patients Treated with Bisphosphonates: An Ultrastructural Study
I. Perrotta et al.
ULTRASTRUCTURAL PATHOLOGY (2010)
Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan
C. I. Ripamonti et al.
ANNALS OF ONCOLOGY (2009)
Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: An analysis of 31 cases with confocal laser scanning microscopy
G. Favia et al.
BONE (2009)
Osteonecrosis of the jaw - Who gets it, and why?
Ian R. Reid
BONE (2009)
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
Konstantinos Vahtsevanos et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Imaging Findings of Bisphosphonate-Related Osteonecrosis of the Jaw With Emphasis on Early Magnetic Resonance Imaging Findings
Anant Krishnan et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2009)
Oral Bisphosphonates as a Cause of Bisphosphonate-Related Osteonecrosis of the Jaws: Clinical Findings, Assessment of Risks, and Preventive Strategies
Leon A. Assael
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Editorial Board
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Resolution of Osteonecrosis of the Jaw After Teriparatide [Recombinant Human PTH-(1-34)] Therapy
Arthur N. Lau et al.
JOURNAL OF RHEUMATOLOGY (2009)
Bisphosphonate Associated Osteonecrosis of the Jaw
Aliya A. Khan et al.
JOURNAL OF RHEUMATOLOGY (2009)
Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy
Parish P. Sedghizadeh et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2009)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Bisphosphonates and Time to Osteonecrosis Development
Pinelopi Kleio Palaska et al.
ONCOLOGIST (2009)
Expression of receptor activator of nuclear factor-κB ligand by B cells in response to oral bacteria
X. Han et al.
ORAL MICROBIOLOGY AND IMMUNOLOGY (2009)
Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells
Fraser P. Coxon et al.
BONE (2008)
Bis-phossy jaws - High and low risk factors for bisphosphonate-induced osteonecrosis of the jaw
Mario H. Abu-Id et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2008)
Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy
Parish P. Sedghizadeh et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2008)
Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study
John H. Wessel et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2008)
Bisphosphonate use and the risk of adverse jaw outcomes
Vassiliki M. Cartsos et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2008)
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture Trial
John T. Grbic et al.
JOURNAL OF THE AMERICAN DENTAL ASSOCIATION (2008)
A woman with a nonhealing ulcer of the jaw - Gingival ulceration, inflammation, and acute osteomyelitis with actinomyces, all associated with necrosis of bone (bisphosphonate-related osteonecrosis of bone)
Thomas B. Dodson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker
M. Pazianas et al.
OSTEOPOROSIS INTERNATIONAL (2008)
No osteonecrosis in jaws of young patients with osteogenesis imperfecta treated with bisphosphonates
Barbro Malmgren et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2008)
Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis
Torsten Hansen et al.
VIRCHOWS ARCHIV (2007)
Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome
N. Yarom et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?
Ian R. Reid et al.
BONE (2007)
Intravenous bisphosphonate therapy and inflammatory conditions or surgery of the jaw: A population-based analysis
Gregg S. Wilkinson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Regulation of RANKL and OPG gene expression in human gingival fibroblasts and periodontal ligament cells by Porphyromonas gingivalis:: A putative role of the Arg-gingipains
Georgios N. Belibasakis et al.
MICROBIAL PATHOGENESIS (2007)
A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma
A. Corso et al.
LEUKEMIA (2007)
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)
Resolution of bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone [rhPTH(1-34)]
Richard P. Harper et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2007)
Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells
Karin Loser et al.
NATURE MEDICINE (2006)
Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis
T Hansen et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2006)
Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease
IR Reid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases
SL Ruggiero et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2004)
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic
RE Marx
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2003)
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: A phase III, double-blind, randomized trial - The zoledronic acid lung cancer and other solid tumors study group
LS Rosen et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Share Paper
